Search For "pfizer"
US to donate 500 million additional Covid vaccines to world
Updated : 4 years, 6 months ago IST
Washington DC [US], September 22 (ANI): The United States is set to announce the purchase of an additional 500 million Pfizer COVID-19 vaccines to donate to low- and lower-middle-income countries around the world, a senior Biden Administration Official informed on Wednesday.
Read More
US FDA: No Pfizer booster shots for 16 and above, approved only for people
Updated : 4 years, 6 months ago IST
Washington [US], September 18 (ANI): The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots for use in people aged 65-plus and high-risk patients following a prior failed vote to approve third shots for all p
Read More
WHO emergency use authorisation to Covaxin delayed till October 5
Updated : 4 years, 6 months ago IST
New Delhi [India], September 18 (ANI): World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
Read More
Pakistan reports 2,988 fresh cases of COVID-19 in last 24 hours
Updated : 4 years, 6 months ago IST
Islamabad [Pakistan], September 13 (ANI): Pakistan reported 2,988 fresh cases of COVID-19 after 53,158 tests were conducted across the country in the last 24 hours, according to Pakistan's National Command and Operation Centre (NCOC) data.
Read More
Australia secures additional 4 million Pfizer vaccines on record day of CO
Updated : 4 years, 6 months ago IST
Canberra [Australia], September 3 (ANI/Xinhua): The Australian government has secured another 4 million doses of coronavirus vaccine in a deal with Britain as the country continued to battle the third wave of COVID-19 infections.
Read More
Study shows downside of not receiving second shot of COVID-19 vaccine
Updated : 4 years, 6 months ago IST
Washington [US], August 31 (ANI): A new study has shown that two months after the second Pfizer/Moderna vaccination, antibody response decreases 20 per cent in adults with prior cases of COVID-19. The study also tested how well current vaccines resist emerging variants.
Read More
CDC panel endorses approval of the Pfizer Covid vaccine for Americans aged
Updated : 4 years, 6 months ago IST
Washington [US], August 31 (ANI/Sputnik): A key advisory panel of the US Centers for Disease Control and Prevention (CDC) said on Monday that it has unanimously endorsed the full approval of the Pfizer-BioNTech's COVID-19 vaccine for Americans aged 16 and older.
Read More
Pfizer jab side effects in 12 to 15-year-olds at high risk of COVID-19 com
Updated : 4 years, 6 months ago IST
London [UK], August 28 (ANI): A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions.
Read More
Pfizer jab side effects in 12-15 year olds at high risk of COVID-19 compli
Updated : 4 years, 6 months ago IST
London [UK], August 27 (ANI): A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions.
Read More
US: FDA gives full approval to Pfizer-BioNTech COVID 19 vaccine
Updated : 4 years, 7 months ago IST
Washington [US] August 23 (ANI): The US Food and Drug Administration (FDA) on Monday gave full approval to Pfizer's COVID-19 vaccine.
Read More
US to roll out COVID-19 vaccine booster shots in September, say health off
Updated : 4 years, 7 months ago IST
Washington [US], August 19 (ANI): Booster shots of the Pfizer and Moderna COVID-19 vaccines are set to become available for all adults in America beginning next month, the country's top health officials announced on Wednesday.
Read More
Pfizer and BioNTech announce submission of Initial data to US FDA to suppo
Updated : 4 years, 7 months ago IST
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Read More